Free Subscription

  • Access 15 free news articles each month

Professional

Try one month for $5
  • Unlimited access to news,insights and opinions
  • Quarterly and weekly magazines
  • Independent research reports and forecasts
  • Quarterly webinars with industry experts
  • Q&A with retail leaders
  • Career advice
  • Exclusive Masterclass access. Part of Retail Week 2021

Australian pharmaceutical industries

Australian pharmaceutical industries Archives

ACCC clears the way for Wesfarmers to acquire Priceline parent

In talking with stakeholders, the ACCC found few concerns about potential market disruption because there are a large nu...

Woolworths pulls bid to pick up pharmacy group API

Woolworths said it was unable to validate the financial returns it would require from the acquisition after completing i...

“We are not here to disrupt the sector”: Woolies’ case to pharmacists

Woolies chief executive Brad Banducci has penned an open letter to Australian pharmacists outlining the supermarket grou...

Rival pharmaceutical company seeks to keep API from Wesfarmers

Sigma Healthcare looks to sweep up its rival before Wesfarmers can create its new division.

Wesfarmers makes revised bid for Priceline-owner

API's board is recommending shareholders back the revised offer, which will now see them paid out at a 37 per cent premi...

From the source: Richard Vincent, Australian Pharmaceutical Industries

API keeps its eye firmly on the Priceline shopper – what motivates her purchases and what she is looking for in the stor...

Priceline parent eyes acquisitions

Pharmacy chain looks to strengthen retail portfolio.

Chemist giants go head to head

Pharmacy chains: To float or not to float?

Priceline parent prescribes profit warning

"Suppressed retail trading conditions” impact on pharmacy chain.

Priceline owner books modest growth

Pharmacy firm speeds up omnichannel investments as subdued discretionary spending and rising competitive pressures threa...

API dispenses bumper profit rise

Enlarged network gives Priceline owner a big boost.

Australian Pharmaceutical CEO steps down

Priceline owner's CEO and MD stepping down, company updates guidance.

From the source: Stephen Roche, Australian Pharmaceutical Industries

Meet the top man from the parent company of Priceline Pharmacy, Soul Pattinson Chemist and Pharmacist Advice.

Lovisa’s chairman and CFO resign

Boardroom shake-up sees new chairman and CFO appointed.

Priceline operator raises guidance

API forecasts profit increase following strong sales at its Priceline outlets.

API warns of writedown

Pharmacies operator to take $131million hit.

Priceline on the up

Competition in health, beauty, and pharmacy is intense, but confidence appears to be improving as API releases 2013 sale...